Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksActiveops Regulatory News (AOM)

Share Price Information for Activeops (AOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.50
Bid: 105.00
Ask: 108.00
Change: 1.50 (1.43%)
Spread: 3.00 (2.857%)
Open: 102.50
High: 106.50
Low: 100.00
Prev. Close: 105.00
AOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

5 Sep 2023 07:00

RNS Number : 3374L
ActiveOps PLC
05 September 2023
 

5 September 2023

ActiveOps plc

("ActiveOps" or the "Company")

Appointment of Chief Financial Officer

 

ActiveOps plc (AIM: AOM), a leading provider of Management Process Automation (MPA) software for running hybrid and global back-office operations, is pleased to announce the appointment to the Board of Emma Salthouse as Chief Financial Officer, with effect from 1 December 2023. In order to reduce his executive time commitments, Ken Smith, current Chief Financial Officer, has decided to step down from his position on the Board on that date, remaining with the Company on a part-time basis for a number of months to oversee an orderly transition of responsibilities.

Emma is a CIMA qualified, experienced finance professional. She was previously the Head of Finance at ActiveOps for c. five years, before joining Forensic Access Limited, a provider of forensic science expertise, as Group CFO. During her time with ActiveOps, Emma oversaw the transformation of the accounting processes and systems of the business and was a key member of the finance team during the preparations for the 2021 IPO. In her most recent role as Group CFO of Forensic Access Group, Emma has orchestrated the centralisation and integration of the finance function, implementing best practice and a robust governance framework.

Sean Finnan, Chairman, commented: "We are delighted Emma has agreed to return to ActiveOps. She was a key element in the professionalisation of our finance function in the build up to IPO and brings fantastic drive to the team as well as a deep understanding of our customers, offering and market.

"Ken has been an excellent guardian of our finance operation. The Board thanks him for his dedication and for his ongoing support as Emma transitions into the role."

Emma Salthouse, incoming CFO, commented, "I am thrilled to return to a business and team I know so well. ActiveOps has gone from strength to strength in recent years, delivering an acceleration in SaaS growth, from a growing list of blue-chip customers. With an expanding product set, the opportunity to build upon that strong foundation is an exciting one and I look forward to working alongside Richard and the team to deliver it."

Schedule Two paragraph (g) disclosures:

 

Emma May Salthouse (32 years old) has been a director or partner of the following companies during the five years preceding the date of the announcement:

 

Past directorships and/or partnerships:

Alecto Forensic Services Limited

Analytical Services International Limited

Econico Limited

Faraday Forensics Ltd

Forensic Access Limited

Forensic Axis Limited

Forensic Futures Limited

Forensis Group Ltd

Intaforensics Ltd

Kind Baby Limited

 

There is no further information required to be disclosed under Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

For more information, please contact:

ActiveOps

Via Alma PR

Richard Jeffery, Chief Executive Officer

www.activeops.com

Ken Smith, Chief Financial Officer

 

Investec Bank plc

+44 (0)20 7597 5970

Corporate Broking & PLC Advisory

Patrick Robb / David Anderson

 

Alma

+ 44(0) 203 405 0205

Caroline Forde / Will Ellis Hancock

 

About ActiveOps

ActiveOps is a leader in Management Process Automation (MPA), providing a SaaS platform to large enterprises with complex and often global back-offices. The Group's software and embedded back-office operations management methodology enables enterprises to adopt a data-driven, scientific approach to organising work and managing capacity.

The Group's enterprise platform comprises its MPA software products and AOM, the Group's operations methodology and framework for effective back-office management. Together, this combination of software and embedded methodology enables operations managers to balance the competing priorities of meeting service and quality standards while improving productivity and reducing cost.

As at 31 March 2023, the Group had 179 employees, serving its global customer base of over 80 enterprise customers from offices in the UK, Ireland, USA, Australia, India and South Africa. The Group's customers are predominantly in the banking, insurance, healthcare administration and business process outsourcing (BPO) sectors, including Nationwide, TD Bank, Elevance and DXC Technology.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKQBBOBKDACK
12
Date   Source Headline
24th Apr 20247:00 amRNSFull Year Trading Update and Notice of Results
19th Apr 20247:00 amRNSDirector/PDMR Dealing
17th Apr 20244:30 pmRNSHolding(s) in Company
3rd Apr 202410:52 amRNSGrant of Options
25th Mar 20247:00 amRNSSenior Leadership Team Appointments
18th Mar 20245:49 pmRNSDirector/PDMR Dealing
26th Feb 20245:58 pmRNSDirector/PDMR Dealing
20th Feb 202412:02 pmRNSDirector/PDMR Dealing
20th Feb 20247:15 amRNSHolding(s) in Company
30th Jan 202410:49 amRNSDirector/PDMR Dealing
19th Jan 20241:00 pmRNSDirector/PDMR Dealing
28th Dec 20233:32 pmRNSDirector/PDMR Dealing
19th Dec 202312:12 pmRNSDirector/PDMR Dealing
7th Dec 20237:00 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSBoard Succession Planning
27th Nov 20234:20 pmRNSDirector/PDMR Dealing
21st Nov 20233:55 pmRNSDirector/PDMR Dealing
14th Nov 20237:00 amRNSInterim Results
10th Nov 20237:00 amRNSNotice of Investor Presentation
8th Nov 20234:29 pmRNSDirector/PDMR Dealing
18th Oct 20234:59 pmRNSDirector/PDMR Dealing
18th Oct 20237:00 amRNSTrading Update and Notice of Half Year Results
28th Sep 202312:48 pmRNSResult of AGM
26th Sep 202311:52 amRNSDirector/PDMR Dealing
26th Sep 20237:00 amRNSLaunch of ControliQ Series 3
18th Sep 20233:01 pmRNSDirector/PDMR Dealing
5th Sep 20237:00 amRNSAppointment of Chief Financial Officer
24th Aug 20232:31 pmRNSDirector/PDMR Dealing
23rd Aug 20235:58 pmRNSPublication of Annual Report and Notice of AGM
18th Aug 20234:59 pmRNSDirector/PDMR Dealing
27th Jul 20231:54 pmRNSHolding(s) in Company
26th Jul 20232:16 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSDirector/PDMR Dealing
18th Jul 20233:46 pmRNSDirector/PDMR Dealing
4th Jul 20237:00 amRNSResults for the year ended 31 March 2023
28th Jun 20234:36 pmRNSDirector/PDMR Dealing
26th Jun 20237:00 amRNSNotice of Results and Investor Presentation
19th Jun 20233:13 pmRNSDirector/PDMR Dealing
25th May 202311:20 amRNSDirector/PDMR Dealing
19th May 20231:14 pmRNSDirector/PDMR Dealing
25th Apr 20237:00 amRNSFull Year Trading Update
24th Apr 20234:41 pmRNSDirector/PDMR Dealing
21st Apr 202311:45 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of new Chief Financial Officer
27th Mar 20231:14 pmRNSDirector/PDMR Dealing
21st Mar 20237:00 amRNSDirector/PDMR Dealing
27th Feb 20237:00 amRNSDirector/PDMR Dealing
20th Feb 202310:38 amRNSDirector/PDMR Dealing
24th Jan 20231:27 pmRNSDirector/PDMR Dealing
18th Jan 202311:18 amRNSDirector/PDMR Dealing
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.